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Background: Around 3–5% of the population suffer from IgE-mediated food allergies in Western countries and the
number of food-allergenic people is increasing. Individuals with certain pollen allergies may also suffer from a sensitisation
to proteins in the food products. As an example a person sensitised to the major birch pollen allergen, Bet v 1, is often
sensitised to its homologues, such as the major allergens of apple, Mal d 1, and celery, Api g 1, as well. Development of
tools for the reliable, sensitive and quick detection of allergens present in various food products is essential for allergic
persons to prevent the consumption of substances causing mild and even life-threatening immune responses. The use of
monoclonal antibodies would ensure the specific detection of the harmful food content for a sensitised person.
Methods: Mouse IgG antibody libraries were constructed from immunised mice and specific recombinant antibodies for
Mal d 1 and Api g 1 were isolated from the libraries by phage display. More detailed characterisation of the resulting
antibodies was carried out using ELISA, SPR experiments and immunoprecipitation assays.
Results: The allergen-specific Fab fragments exhibited high affinity towards the target recombinant allergens.
Furthermore, the Fab fragments also recognised native allergens from natural sources. Interestingly, isolated Mal d 1-
specific antibody bound also to Bet v 1, the main allergen eliciting the cross-reactivity syndrome between the birch pollen
and apple. Despite the similarities in Api g 1 and Bet v 1 tertiary structures, the isolated Api g 1-specific antibodies showed
no cross-reactivity to Bet v 1.
Conclusions: Here, high-affinity allergen-specific recombinant antibodies were isolated with interesting binding
properties. With further development, these antibodies can be utilised as tools for the specific and reliable detection of
allergens from different consumable products. This study gives new preliminary insights to elucidate the mechanism
behind the pollen-food syndrome and to study the IgG epitope of the allergens.Background
Allergy is an immunological hypersensitivity disorder to
substances in food, air or medical and consumer prod-
ucts, which are normally harmless. At least 30% of the
population suffer from IgE-mediated allergic reactions
and around 3–5% of them suffer from IgE-mediated
food allergies in westernised countries and the number
of allergenic people is dramatically increasing [1, 2]. One
of the main elicitor of type I allergic reactions worldwide* Correspondence: jaana.haka@vtt.fi
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unless otherwise stated.is birch pollen and more precisely one of its major aller-
gens, Bet v 1 [3, 4]. Bet v 1, a 17.4-kDa protein belonging
to pathogenesis-related plant proteins (PR-10), is respon-
sible for over 95% of the allergies to birch pollen [5, 6].
Interestingly, over 70% of persons sensitised to birch
pollen allergens display adverse reactions to fruits and
vegetables as well [7]. Moreover, fresh apple is the most
frequently reported food ingredient causing adverse reac-
tions among birch-pollen sensitised individuals [2, 5, 8].
The major apple allergen, Mal d 1, is a 17.5-kDa pro-
tein and the member of the same pathogenesis-related
protein family that includes Bet v 1 [9]. Mal d 1 and Bet
v 1 share approximately 65% amino acid sequencehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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most important plant food allergen associated with birch
pollen sensitisation especially in European countries. It
is able to trigger a wide range of allergic symptoms vary-
ing from mild oral responses to life-threatening anaphyl-
axis [2, 10, 11]. The most important allergen in celery
tuber is a 16.2-kDa protein Api g 1, also a member of
the pathogenesis-related protein family [12]. Api g 1 is a
Bet v 1 -homologous protein with approximately 40%
amino acid sequence identity with both Bet v 1 and Mal
d 1 [12-14].
Interestingly, all of the 1500 allergens identified today
are classified to belong to only 2% of known protein
families with implications to similar structural and func-
tional characteristics. Furthermore, high homology in
the amino acid sequence of the proteins within the same
protein family results in homologous secondary and ter-
tiary structures and hence common epitopes of homolo-
gous proteins, such as Mal d 1, Api g 1 and Bet v 1. It is
surprising, that high homology in protein primary, sec-
ondary or even tertiary structure does not necessarily
convert into IgE epitope cross-reactivity [15].
Several studies have been conducted in order to ex-
plain the cross-reactivity between Bet v 1 and its hom-
ologous food allergens, such as Mal d 1 and Api g 1.
They are mainly based on molecular modelling, cross-
reactive IgE epitope mapping, epitope grafting [16, 17],
site-directed mutagenesis [18, 19] or overlapping pep-
tides representing allergens [20]. The crystal structure
for the Bet v 1 - IgG Fab fragment BV16 complex has
been solved [21] but only a limited amount of informa-
tion is available on specific antibodies for Mal d 1 or Api
g 1. Few monoclonal antibodies have been raised against
Mal d 1 using hybridoma technology and their binding
to Bet v 1 has been studied, but only a few of these anti-
bodies cross-reacted with Bet v 1 when characterised by
immunoblotting and ELISA [22, 23].
The solved allergen-antibody crystal structures strongly
imply the importance of native allergen conformation in
antibody binding experiments [21, 24-29]. Phage display
technology and the availability of large and diverse anti-
body libraries enable the isolation of allergen-specific
recombinant antibodies in a conformation-dependent
manner in vitro [30, 31]. The bacterial production of
functional antibody fragments and their efficient display
on a filamentous phage particles have made it possible
to construct large and diverse combinatorial antibody
phage display libraries for the isolation and evolution of
antibodies with an enormous diversity in binding speci-
ficities and affinities [32]. In phage display technology,
an active antigen/allergen-binding antibody fragment
(scFv or Fab fragment) can be displayed on the surface
of the phage particle containing the DNA encoding the
particular antibody and, thus, the phenotype is linked tothe genotype. By this method it is possible to identify
antibody phage particles binding specifically to the desired
antigen/allergen. Nowadays, several allergen-specific IgE
and IgG antibody display libraries have been constructed
and recombinant antibodies isolated e.g. against pollen,
cow’s milk and latex allergens [30, 31, 33-36].
Here we have isolated IgG antibodies specific for
major allergens in apple, Mal d 1 and celery, Api g 1 by
the construction and selection of mouse IgG Fab frag-
ment phage display libraries. Recombinant allergens,
rMal d 1 and rApi g 1 were expressed and validated prior
to mouse immunisations. High-affinity allergen-specific
antibodies to rMal d 1 and rApi g 1 were generated using
phage display technology. The binding properties and
kinetics of the isolated allergen-specific antibodies were
characterised utilising the recombinant allergens as well
as native allergens from natural sources. The binding
properties of the resulting antibodies were also studied
against their known homologue, Bet v 1. Interestingly,
one of the isolated rMal d 1-specific antibodies bound
also to major birch pollen allergen rBet v 1, the main al-
lergen eliciting the cross-reactivity syndrome between
the birch pollen and apple. Despite the similarities in
Api g 1 and Bet v 1 tertiary structures, the isolated anti-
bodies against rApi g 1 showed no cross-reactivity to
rBet v 1 at least within the selected antibodies. These
isolated allergen-specific antibodies can be utilised as
diagnostic and research tools for detecting allergens and
studying allergy-antibody interactions.
Results
Characterisation of the recombinant Mal d 1 and Api g 1
Recombinant allergens, rMal d 1 and rApi g 1 were
expressed without any tags or fusions and purified by a
two-step chromatography method. The yield from the
1.8-l bacterial culture was 6 mg for rMal d 1 and 17 mg for
rApi g 1. According to the analysis of a Coomassie-stained
SDS-PAGE gel, the recombinant allergens were purified to
a substantial homogeneity (data not shown). In order to
further confirm the purity and homogeneity of the purified
rApi g 1 and rMal d 1, the accurate molecular masses
of the allergens were determined using an ultrahigh-
resolution ESI FT-ICR mass spectrometry in denaturing
solution conditions. The experimentally determined mo-
lecular mass of rApi g 1 (averaged over the charge state
distribution) was 16188.78 ± 0.02 Da, which agrees well
with the theoretical mass calculated from the full amino
acid sequence of Api g 1 (16188.48 Da). The mass
spectrum also revealed a partial oxidation of the pro-
tein, most likely in a single methionine residue of rApi
g 1 (16204.77 Da, Fig. 1).
On the contrary, the experimentally determined mo-
lecular mass of rMal d 1 (17695.27 ± 0.01 Da, Fig. 2a) was
higher than the expected mass of the mature allergen
Fig. 1 ESI FT-ICR mass spectrum of rApi g 1 measured in MeCN:H2O: HOAc (49.5:49.5:1.0, v/v). Numbers denote different protein ion charge states.
The deconvoluted mass spectrum has been presented in blue at the right side of the charge-state spectrum. Two protein forms observed in mass
spectrum present the full-length (1) and oxidized rApi g 1 (2)
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and theoretical masses was 176.30 Da. To find out a rea-
son for the observed mass difference, rMal d 1 was enzy-
matically digested with trypsin. The peptides observed in
a mass spectrum of a tryptic digest of rMal d 1 coveredFig. 2 Deconvoluted ESI FT-ICR mass spectra of rMal d 1 measured in MeC
been presented before (a) and after (b) DTT-reduction77% of the amino acid sequence of the protein (10 specific
tryptic peptides were found, data not shown). Tryptic pep-
tides were not found in the areas spanning the amino
acids residues 19–40 and 105–115, thus indicating the lo-
cation of the possible modification. Interestingly, the latterN:H2O: HOAc (49.5:49.5:1.0, v/v). The deconvoluted mass spectrum has
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residue C107. Free thiol groups of non-disulfide bridged
cysteine residues might be highly reactive and, thus, par-
ticipate in several electrophilic and oxidative modifications
[37]. One of the commonly observed modifications in free
cysteine-containing human plasma proteins is the S-
cysteinylglycinylation (S-CysGly), which results in a mass
increment of +176 Da per each cysteine residue [38, 39].
To analyse whether the observed mass difference in rMal
d 1 was caused by the S-CysGly modification, the protein
was incubated with a reducing agent. The mass spectrum
measured after reduction revealed that the +176.30 Da
modification disappeared and the molecular mass of the
allergen (17519.03 ± 0.01 Da) corresponded with the
theoretical mass (Fig. 2b). The cysteinylglycine dipep-
tide is also a metabolite of E. coli, which explains the
finding of S-CysGly modification in a recombinant
protein. When S-CysGly was included as the variable
modification in the peptide fingerprinting, one add-
itional tryptic peptide was found (residues 98–114),
which contains an S-CysGly modified cysteine residue
(C107). Hence, the final sequence coverage increased
to 84%.
Both rApi g 1 and rMal d 1 contain a single cysteine
residue. In the crystal structure of rApi g 1 (PDB:2BK0,
[14]), the cysteine residue C114 is buried in the interior
of the folded protein. Although the three-dimensional
structure of rMal d 1 is not known, the sequence com-
parison and the mass spectrometric analyses indicate
that the C107 is located on the solvent-exposed loop
region and, thus, being highly susceptible for oxidative
modifications. rMal d 1 and rApi g 1 were used for subse-
quent mouse immunisations, selections as well as for the
screening and characterisation of the allergen-specific Fab
fragments.
Construction and characterisation of the mouse IgG Fab
fragment libraries
In order to select the immunised mouse with the highest
IgG antibody response against the target allergens, the
sera from the immunised mice were tested (Figs. 3a
and b). According to the ELISA result, all of the analysed
sera expressed considerable IgG immune responses
against the target allergens. Based on these results,
mouse 1 (M1) and mouse 2 (A2) were selected for the
construction of anti-rMal d 1 and anti-rApi g 1 Fab
fragment library, respectively. Serum of mouse M1 and
A2 was also analysed against potentially cross-reactive
allergens, rMal d 1, rApi g 1 and rBet v 1 (Fig. 3c). The
results show binding of both rMal d 1 and rApi g 1
immunised mouse sera IgG against rBet v 1. However,
rMal d 1 immunised mouse serum IgG showed no
binding against rApi g 1 and rApi g 1 immunised
mouse serum did not bind to rMal d 1.Transformation of anti-rMal d 1 and anti-rApi g 1 Fab
fragment libraries into E. coli XL1-Blue cells resulted in
mouse IgG Fab fragment libraries with approximately
107 and 105 independent clones for anti-rMal d 1 and
anti-rApi g 1 Fab fragment library, respectively. Accord-
ing to the DNA sequences of the individual unselected
Fab fragment clones, all analysed DNA sequences were
different in relation to each other (data not shown).
Isolation of allergen-specific mouse IgG Fab fragments
The selection of the rMal d 1 and rApi g 1 -specific anti-
body phage libraries was carried out in solution using bi-
otinylated rMal d 1 and rApi g 1, respectively. To follow
the enrichment of the selected clones, the ratio between
positive (i.e. allergen) versus negative (i.e. BSA) selection
were calculated after each selection round. The enrich-
ment was more efficient during anti-rMal d 1 than
anti-rApi g 1 antibody selection (data not shown).
After the second selection round, the phage pool
ELISA was performed for the unselected Fab fragment
phage library and for the both enriched Fab fragment
phage libraries. According to the rMal d 1 and rApi g 1
-specific Fab fragment phage library ELISA, a clear en-
richment between the selection rounds was observed
(data not shown).
Due to observed enrichment in phage pools, individual
rMal d 1 and rApi g 1 -specific Fab fragment phage
clones were prepared and subjected to ELISA. Total of
96 individual clones from the first and the second selec-
tion round were screened for the rMal d 1 and rApi g 1
-specific individual clones by a preliminary ELISA (data
not shown). For rMal d 1-specific binders, 35% of the
analysed clones from the first selection round and 81%
from the second selection round bound to the target al-
lergen. For rApi g 1 binders, the percentages were 13%
for the first and 33% for the second selection round. The
total of 24 individual rMal d 1 and rApi g 1 -specific
antibody phage clones were subjected to a secondary
ELISA and screened parallel with BSA background
(Fig. 4). In the secondary ELISA, all of the individual
phage clones showed binding to the target allergen.
Based on the target allergen binding, the total of ten
most promising clones of both rMal d 1 and rApi g 1
-specific antibodies were subjected to DNA sequencing.
The results showed a clear similarity between the DNA
sequences of each allergen-specific Fab fragments. All
other clones were different except two anti-rApi g 1 Fab
fragment clones. There were two identical sequences
(AA11 and AC11) out of ten clones. Two Fab fragment
clones per allergen, designated as MA1 and MB3 for
rMal d 1-specific and AH7 and AA11 for rApi g 1-
specific, were chosen for further characterisation. The
variations in the sequences and binding profiles of the
Fab fragments were used as the selection criteria. The
Fig. 3 Serum IgG responses of the immunised mice analysed by ELISA. The binding of the mouse serum IgGs to immobilised rMal d 1 (M1–M3)
(a), rApi g 1 (A1–A4) (b) has been analysed. Serum IgG responses of the immunised mice M1 and A2 has also been analysed against the
potential cross-reactive allergens, rMal d 1, rApi g 1 and rBet v 1 (c). Dilutions of the rMal d 1 (1:200) and rApi g 1 (1:1000) immunised mouse
serum samples have been selected according to the Figs. 3a and b, respectively. The results present the mean values of the duplicate
samples (±SD)
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lected anti-rMal d 1 and anti-rApi g 1 Fab fragments
were determined and are shown in Table 1. Similarity of
the amino acid sequences between the two allergen-
specific Fab fragments MA1 and MB3 as well as AH7
and AA11 is expectedly seen, with a minimum of one
amino acid difference in the CDRs. For rApi g 1-specific
Fab fragment clones, CDRs for heavy framework 1 and 3
(HCDR1 an HCDR3, respectively) and light framework 2
(LCDR2) are identical.
Characterisation of binding properties of the
allergen-specific mouse IgG Fab fragments
To further characterise the allergen-binding properties
of the MA1 and MB3 as well as AH7 and AA11 Fabfragment, they were produced in a larger scale as soluble
Fab fragments containing hexahistidine tag and, thus,
purified from the culture supernatant by IMAC. The
purification yield of the Fab fragments from 900 ml of
culture supernatant was approximately 1 mg for all of
the Fab fragments, except for the MA1 Fab fragment
with 7.8 mg. After the purification, the Fab fragments
were subjected to the competitive ELISA to assess their
binding specificity against their target allergens in more
detail (Fig. 5). The Fab fragments showed specific bind-
ing to the target allergens as their binding to the target
allergens was displaced in a concentration-dependent
manner by a competing allergen.
The binding affinities and kinetics were further ana-
lysed by Surface Plasmon Resonance (SPR) experiments
Fig. 4 Screening of the rMal d 1 and rApi g 1 -specific antibody phages by ELISA. The specific binding of the individual anti-rMal d 1 (a) and
anti-rApi g 1 (b) Fab fragment phage clones against their target allergen and BSA background has been analysed
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the MA1 and MB3 Fab fragments showed higher affinity
than the AA11 and AH7 Fab fragments to the target al-
lergens. The MA1 Fab fragment bound rMal d 1 with
the higher affinity compared to MB3 Fab fragment (KD
of 3.3 nM and 19.7 nM, respectively). Furthermore, the
AH7 Fab fragment bound rApi g 1 with slightly higher
affinity compared to AA11 Fab fragment (KD of 0.54 μM
and 0.70 μM, respectively).
In ELISA and SPR experiments, the analysis of the
binding properties of the Fab fragments was carried out
using purified, recombinant allergens. Next, the ability
of Fab fragments to recognise the native allergen ex-
tracted from a natural source was analysed using immu-
noprecipitation assay. All of the allergen-specific Fab
fragments precipitated their target native allergen as well
as purified recombinant allergen (Fig. 6).
Due to Mal d 1, Api g 1 and Bet v 1 amino acid se-
quence similarity, structural similarity of Api g 1 and Bet
v 1 allergens [14, 40] as well as the observed cross-
reactivity of the immunised mice sera (Fig. 3c), the
cross-reactivity of the Fab fragments against the rBet v 1
was analysed by ELISA (data not shown), immunopre-
cipitation assays (Fig. 7) and SPR experiments (Table 3).Table 1 CDRs of the allergen-specific Fab fragments
Fab HCDR1 HCDR2 HCD
MA1 GFTFSAYGMS TISNGGTYTYYQDSVKG PPSRG
MB3 GFTFSNYGMS TISSGGSYTYYPDSVKG PPSKG
AH7 GFDFSRYWMS EINPDSSTINYTPSLKD FPMDY
AA11 GFDFSRYWMS EINPDSSTINYPPSLKD FPMDY
Differences between the same allergen-binding Fab fragments are indicated in boldThe Fab fragment in the culture supernatant or as puri-
fied form were allowed to bind rMal d 1, rBet v 1, rApi g
1 and BSA. Only the anti-rMal d 1 Fab fragment clone
MA1 showed cross-reactivity against rBet v 1. The result
was confirmed using purified Fab fragments in ELISA
and SPR experiments. The MA1 Fab fragment bound
rBet v 1 with lower affinity than rMal d 1 (KD of 29.7
nM and 3.3 nM, respectively). There were no observable
binding of anti-rApi g 1 Fab fragments or anti-rMal d 1
Fab fragment MB3 against any other than their target
allergen.
The usability of allergen-specific Fab fragments for
food allergen detection was studied by sandwich ELISA
(Fig. 8). The sandwich ELISA proved to be functional
with both of the combinations of allergen-specific Fab
fragment and antibody-phage fusion. The result of the
sandwich ELISA for rMal d 1 and rApi g 1 are shown in
Fig. 8b.
Discussion
Combinatorial antibody phage display technology has
proven to be highly powerful technique for the isolation
of target-specific IgE and IgG antibodies for a wide var-
iety of molecules [30, 31, 33-36]. Here, we were able toR3 LCDR1 LCDR2 LCDR3
GYFDV RASENIYSNLA AAKTLAD QHFWSTPFT




Fig. 5 Binding properties of the Fab fragments analysed by competitive ELISA. The binding properties of the purified anti-rMal d 1 (a) and
anti-rApi g 1 (b) Fab fragments have been analysed. The results present the mean values of the duplicate samples (±SD)
Haka et al. BMC Biotechnology  (2015) 15:34 Page 7 of 15isolate several unique and specific recombinant Fab frag-
ments exhibiting high affinity against recombinant and
native Mal d 1 and Api g 1, the major apple and celery
allergen, respectively. To our best knowledge, this is
the first study reporting the isolation of monoclonal
antibodies against Api g 1 and the second study after
Fahlbusch et al. [23] reporting isolation of monoclonal
antibodies against Mal d 1. We characterised the bind-
ing properties of the isolated recombinant antibodies
in more detail compared to the earlier published studies
of Mal d 1 antibodies including ELISA, SPR experiments
and immunoprecipitation assays. The allergen-specific Fab
fragments bound to their target allergen with high affinity
(10−7–10−9 M). These results correlate with the affinities
of human IgE antibodies against β-lactoglobulin [30] and
hevein (unpublished, Laukkanen et al.) isolated using a
similar phage display approach. The rMal d 1-specific Fab
fragments are higher in their affinities (10−8–10−9 M)
against their target allergen compared to rApi g 1-specific
Fab fragments (10−7 M). Both rApi g 1-specific Fab frag-
ments AH7 and AA11 behave similarly when studied in
competitive ELISA and SPR experiments. Interestingly,
although the differences between the isolated rMal d
1-specific Fab fragments MA1 and MB3 in the aminoTable 2 The kinetic constants of allergen-specific Fab fragments me
Allergen Fab ka (1/Ms)
rMal d 1 MA1 7.340 × 105 ± 1.3 × 103
rMal d 1 MB3 2.990 × 105 ± 1.6 × 103
rApi g 1 AH7 8.056 × 104 ± 1.6 × 103
rApi g 1 AA11 8.533 × 104 ± 5.1 × 102
The association (ka) and dissociation (kd) rate constants and affinity constant (KD) ha
(±SD) obtained with seven different Fab fragment concentrations.acid sequence level are minor (Table 1), their influence
to the allergen binding properties is significant. While
the allergen-binding properties of MA1 and MB3 Fab
fragments are similar according to the rate constants,
there is 10-fold difference in their affinity constants
(Table 2). The MA1 and MB3 Fab fragments have
minor differences in all of their CDRs, including
HCDR3 which is especially important for antibody
specificity [41]. The AH7 and AA11 Fab fragments, on
the other hand, have identical HCDR3 as well as
HCDR1 and LCDR2, which may explain similar bind-
ing characteristics.
Allergens of the Bet v 1 protein family, such as major
allergens in apple, Mal d 1, and in celery, Api g 1, are
the main cause of pollen-related food allergies after the
first sensitisation to birch pollen. Moreover, persons sen-
sitised to Bet v 1 are often sensitised to its homologues,
such as Mal d 1 and Api g 1 as well. Despite the globally
observed adverse connection among birch pollen sensi-
tised individuals to certain food ingredients, such as
apple and celery, there remain a lack of published data
concerning the molecular mechanism of the cross-
reactivity. Antibodies are great tools for deepening the
understanding of molecular interactions initiating anasured by BIAcore
kd (1/s) KD (M)
0.002427 ± 2.1 × 10−6 3.306 × 10−9
0.005890 ± 2.1 × 10−5 1.970 × 10−8
0.04323 ± 7.6 × 10−4 5.366 × 10−7
0.05931 ± 2.1 × 10−4 6.950 × 10−7
ve been measured for the Fab fragments. The values present the averages
Fig. 6 Binding of the Fab fragment to the native allergen analysed by immunoprecipitation assay. An apple extract precipitated with MA1 Fab
fragment is shown here. A silver-stained SDS-PAGE gel with low molecular weight marker (lane 1), only beads (lane 2), beads incubated with Fab
fragment (lane 3), beads incubated with Fab fragment and allergen extract containing the native form of Mal d 1 (lane 4), beads incubated with
Fab fragment and purified rMal d 1 (Biomay, lane 5), beads incubated with allergen extract containing the native form of Mal d 1 (lane 6), Fab
fragment control (lane 7) and purified rMal d 1 control (Biomay, lane 8). The arrow is showing Mal d 1
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Bet v 1-specific human IgE scFv fragment containing a
VH with human origin and a synthetic VL. While study-
ing its cross-reactivity against Mal d 1, they concluded
that the absence of cross-reactivity was due to a less access-
ible Mal d 1 residue E148 compared to that of Bet v 1. Ac-
cording to Levin et al. [36] who were able to isolate Bet v
1-specific human monoclonal IgE from the combinatorialFig. 7 Binding of the MA1 Fab fragment to rBet v 1 measured by immuno
weight marker (lane 1), only beads (lane 2), beads incubated with Fab fragme
4), beads incubated with Fab fragment and rMal d 1 (Biomay, lane 5), beads i
1 control (Biomay, lane 8). The arrow is showing rBet v 1antibody fragment library, the antibody did not cross-react
with Mal d 1 due to differences occurring in the segment
consisting of interactive allergen residues I56-K65. Al-
though allergic reactions are IgE-mediated, it has been
recognised that allergen-IgG complex can serve as a model
for the study of allergen-IgE interactions [21]. Previously
isolated anti-Bet v 1 IgG antibody BV16 [21] is not showing
cross-reactivity towards Mal d 1 but to the point mutatedprecipitation assay. A silver-stained SDS-PAGE gel with low molecular
nt (lane 3), beads incubated with Fab fragment and rBet v 1 (Biomay, lane
ncubated with rBet v 1 (lane 6), Fab fragment control (lane 7) and rBet v
Table 3 The kinetic constants of MA1 Fab fragment against rBet v 1
Allergen Fab ka (1/Ms) kd (1/s) KD (M)
rBet v 1 MA1 1.986 × 105 ± 2.8 x 103 0.005705 ± 5.2 x 10−5 2.972 × 10−8
The association (ka) and dissociation (kd) rate constants and affinity constant (KD) have been measured for MA1 Fab fragment against rBet v 1. The values present
the averages (±SD) obtained with seven different Fab fragment concentrations.
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et al. [14] compared the crystal structures of Bet v 1 and
Api g 1, and they concluded that Api g 1 lacks the resi-
due E45 which has been shown to be crucial for IgG
antibody BV16 binding against Bet v 1 [21] and, thus,
explaining the absence of cross-reactivity. Here we ana-
lysed the binding of the anti-rMal d 1 and anti-rApi g 1
Fab fragments against rBet v 1. Based on the binding
studies, the rMal d 1-specific MA1 Fab fragment bound
also to rBet v 1. The SPR experiment showed that
the complex formation occurred with the high affin-
ity (10−8 M, Table 3) and indicates that the MA1
Fab fragment association with rBet v 1 requires ap-
proximately 3.7-fold more time than association with
rMal d 1. According to the results, there are no binding
of MB3 Fab fragment against rBet v 1. This further un-
derlines the remarkable effect of the minor differences
in the amino acid sequences of the Fab fragments to
their binding characteristics. According to the results,
rApi g 1-specific Fab fragments exhibit no binding to
rBet v 1. These findings are in congruent with previous
studies of Fahlbusch et al. [23], where only three of the
eight studied Mal d 1-specific antibodies showedFig. 8 Sandwich ELISA. The sandwich ELISA principle (a) and result (b) are
antibody is the purified Fab fragment (MB3 or AH7 Fab fragment) whereas
(MA1 or AA11 Fab fragment displaying phage). The front view of Bet v 1 (l
are from Protein Data Bank. Since Mal d 1 crystal structure is not accessible
Mal d 1 allergencross-reactivity against Bet v 1. Also the smaller size of
the Fab fragment library (105 clones) constructed from
the Api g 1 immunised mouse (A2) compared to the
anti-Mal d 1 Fab fragment library (107 clones) resulted
in the lower number of the Fd region and light chain
combinations and this might explain the lack of Bet v 1
cross-reactive clones. Additionally, the anti-Api g 1 Fab
fragments isolated from the antibody library showed
around ten-fold lower binding affinity (Table 2) compared
to the anti-Mal d 1 Fab fragments and this might have an
effect to the result as well. Therefore, even though none of
the studied rApi g 1-specific Fab fragments exhibit cross-
reactivity against rBet v 1, it is possible to find cross-
reactive clones by analysing more clones gained from
combinatorial phage display library as rApi g 1 immunised
mouse sera IgG showed binding against rBet v 1.
Even the intake of trace amount of food allergens can
cause a minor to a fatal allergic reaction to sensitised in-
dividuals. Therefore, it is important to have reliable and
sensitive methods for the detection of a minute amount
of allergens in different food matrices. Traditionally the
diagnostics of allergens are based on the use of human
IgE serum pools isolated from allergic patients. The useshown to one sandwich couple per allergen. The immobilised
the detection antibody is displayed on the tip of the phage particle
eft, PDB:1BV1, [40]) and Api g 1 (right, PDB:2BK0, [14]) crystal structures
, the structure of its homologue Bet v 1 was used here as a model of
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tection of the harmful food content for a sensitised per-
son. In addition to consumer-safety issues, there are also
international regulations for labelling food containing
allergenic ingredients [42]. Allergen-specific IgG Fab
fragments can be utilised as tools for allergen detection
purposes especially in sandwich ELISA, lateral flow and
microarray-based test kits to improve food safety [43].
Here, we have shown by using immunoprecipitation as-
says and allergen extracts from apple and celeriac for
Mal d 1 and Api g 1, respectively, that the isolated Fab
fragments recognise also their target allergens extracted
from the natural sources. For better detection, the affinity
maturation can be used to further improve sensitivities of
the Fab fragments if needed [44]. Here, we have also
shown by using a sandwich ELISA that these allergen-
specific Fab fragments may have great potential in food al-
lergen detection applications in form of ELISA or lateral
flow-based assays.
Despite the enhanced potential and effort put in char-
acterising molecular properties of allergens, only a few
studies have aimed at understanding the differences
between the allergenic IgE and immunogenic IgG epi-
topes of the allergens. Based on the published antibody-
allergen structures, it has been concluded that although
IgE and IgG epitopes differ in geometrical structure they
share some similarities originating from the producing
state of the antibodies [45]. Here we demonstrate that
allergen-specific Fab fragments isolated by the conform-
ational manner using antibody phage display technology
are useful tools in studies of these allergen-antibody
interactions. Future studies include expanding the idea
of using phage display library derived allergen-specific
antibodies as tools for characterising allergen-antibody
structures and epitopes of human antibodies. Human
IgE and IgG phage display libraries have been success-
fully constructed from sensitised persons [e.g. 33, 35]
and IgE and IgG antibodies isolated for instance against
food allergens [30] and Bet v 1 [33, 36]. Therefore, it is
of interest to compare whether similar cross-reactive
antibodies can be isolated from the allergen-specific
human IgEs. Also, to further compare the antibody-
allergen interactions, crystal structures of the antibody-
allergen immunocomplexes are needed [29]. Crystal struc-
tures may reveal antibody-binding epitopes and therefore,
could be used to find out whether MA1 and MB3 Fab
fragments recognise different Mal d 1 epitopes.
Conclusions
In summary, we have isolated and identified in more de-
tails a total of four novel, two rMal d 1 and rApi g 1
-specific, Fab fragments with the high affinities from the
mouse IgG Fab fragment libraries. We have demon-
strated that these allergen-specific antibodies recognisetheir targets presented either as a recombinant or native
protein. The binding ability of antibody to its target food
allergen as its native form prevalent in natural sources is
important when designing detection methods for tracing
allergens from different food matrices. Interestingly, one
of the rMal d 1-specific Fab fragments bound also to
rBet v 1, hence exhibiting cross-reactivity. Therefore,
this study gives new preliminary insights to elucidate the
mechanism behind the pollen-food syndrome as well as
to study the IgG epitope of the allergens.
Methods
Production of recombinant Mal d 1 and Api g 1
Recombinant major apple and celery allergens, rMal d 1
and rApi g 1, respectively, were produced as soluble,
non-fusion proteins in bacterial cells using pKKtac ex-
pression vector and Escherichia coli strain RV308 as
described by Takkinen et al. [46]. Briefly, expression of
recombinant proteins in bacterial cells resulted in the se-
cretion of soluble proteins into the periplasmic space.
Allergens were isolated from the periplasm by osmotic
shock as described by Boer et al. [47]. Purification was
performed by hydrophobic interaction chromatography
(HIC, Phenyl Sepharose 6 Fast Flow medium, GE
Healthcare) with a linear gradient of 20 mM monoso-
dium phosphate buffer containing 1 M NaCl at pH 5.0
and 20 mM Tris buffer containing 7.5% isopropanol at
pH 9.3 followed by size exclusion chromatography
(HiLoad Superdex 75 Column, GE Healthcare) with
PBS as elution buffer. Purified allergens were analysed
by Coomassie-stained SDS-PAGE gels and validated by
mass spectrometry. As control proteins, commercially
available recombinant allergens rMal d 1 (Mal d 1.0108),
rApi g 1 and the major birch pollen allergen, rBet v 1 (Bet
v 1.0101), were purchased from Biomay.
Mass spectrometric measurements were performed with
an APEX-Qe Fourier transform ion cyclotron resonance
(FT-ICR) mass spectrometer (Bruker Daltonics, Billerica,
MA, USA), equipped with a 12 T superconducting magnet
and a Bruker Apollo-II Ion-Funnel ESI source. Before mass
spectrometric analyses, protein samples were purified
from the buffering salts with PD-10 columns (Amersham-
Biosciences), using MS-compatible ammonium acetate
buffer (10 mM, pH 6.9) as an eluent. For mass spectro-
metric measurements in denaturing solution conditions,
protein samples were diluted to 2 μM with MeCN:H2O:
HOAc (49.5:49.5:1.0, v/v) and the solution was introduced
by a syringe pump with the flow rate of 1.5 μl/min into
the ion source. Nitrogen was used as the drying (250°C,
6 mbar) and nebulizing gas. Ions from the ESI-source
were accumulated in the hexapole ion trap for 1.0 s and
transferred to the ICR cell for trapping, excitation and de-
tection. Data collection and processing were carried out
by using Bruker XMASS software (version 7.0.8). For
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time-domain transients were recorded and fast Fourier
transformed before the magnitude calculation. Mass spec-
tra were calibrated externally with respect to the ions of
an ES Tuning Mix (Agilent Technologies).
For trypsin digestion, lyophilized trypsin from bovine
pancreas (Sigma Aldrich) was dissolved in 10 mM am-
monium bicarbonate buffer (pH 8.2) and mixed with
rMal d 1 solution using an enzyme:protein ratio of 1:30
(w/w). The sample was incubated for four hours at 37°C.
The digestion was quenched by adding a small amount
of formic acid and the digest was frozen at − 20°C. Before
mass spectrometric analysis, the sample was diluted to
2 μM with acetonitrile. The mass spectrum was recorded
as described earlier. The digestion spectrum was inter-
preted using DataAnalysis 4.0 software (Bruker Daltonics)
and the tryptic peptides were identified using GPMAW
software (version 9.22, Lighthouse data).
In order to study the effect of the free cysteine residue
to the observed mass difference, the rMal d 1 was re-
duced by incubating the protein solution with 10 mM
dithiothreitol (DTT) at 37°C for three hours. The dena-
tured mass spectrum was recorded immediately after the
DTT reduction.
Construction of the mouse anti-Mal d 1 and anti-Api g 1
IgG Fab fragment libraries
Total of four BALB/c mice per allergen were immunised
separately with rMal d 1 and rApi g 1. All the mouse ex-
periments were in accordance with adequate guidelines
on animal welfare guided by Institutional Animal Ethics
Committee, Committee for the Purpose of Control and
Supervision of Experiments on Animals in India and
Animal Experiment Board in Finland. Serum IgG re-
sponses of three rMal d 1 and four rApi g 1 immunised
mice were determined by ELISA. The biotinylated aller-
gen (0.5 μg) was immobilised onto streptavidin (SA)
-coated microtiter plate wells (Kaivogen). Dilution series
of the serum samples were added to the allergen-coated
wells and incubated for an hour at room temperature
with agitation. The binding of IgG antibodies to the al-
lergens was detected using AFOS-conjugated goat anti-
mouse IgG (H + L) (BioRad) and p-nitrophenylpho-
sphate substrate (Sigma Aldrich). The absorbance values
were measured at 405 nm (SPECTROstar Omega, BMG
Labtech). The binding of IgG fragments from the sera of
rMal d 1 and rApi g 1 immunised mice were also ana-
lysed against rBet v 1. Serum dilutions of 1:200 and
1:1000 were used for rMal d 1 and rApi g 1 immunised
mouse serum, respectively.
Based on the ELISA result, spleens from the mouse
with the highest serum IgG responses against rMal d 1
and rApi g 1 were chosen for the Fab fragment library
construction. Spleens were homogenised (Polytron PT1200 Homogenizator, Kinematica) and total RNA was
isolated according to the RNeasy Midi Kit protocol
(Qiagen). First strand cDNA synthesis was carried out
using Transcriptor First Strand cDNA Synthesis Kit
(Roche) according to manufacturer’s protocol and using
oligo (dT) primer. Mouse kappa light chains and IgG
heavy chains were amplified separately from the synthe-
tized cDNA by using primers based on an article from
Krebber et al. [48]. Briefly, 3’ primers were designed for
annealing to the constant coding regions (CL and CH1)
and a total of 17 and 19 different 5’ primers for the amp-
lification of light and heavy variable domains (VL and
VH), respectively. The amplification was carried out in a
two-step PCR reaction. The first step produced ampli-
fied regions that were used as a template for the second
PCR reaction. In the second step specific restriction sites
were added to the 5’ end of the DNA fragments. The
same set of 3’ primers containing specific restriction
sites were used for the primary and the secondary ampli-
fication reaction. The amplified light and Fd regions
were ligated into pJET1.2/blunt cloning vector (Thermo
Scientific) as blunt-end fragments and cleaved with spe-
cific restriction enzymes to improve cloning efficiency to
a final phagemid vector, a display vector. Finally, the
amplified and digested DNA fragments encoding light
chains and Fd regions were pooled and cloned into the
previously described phagemid vector [31]. The resulting
mouse anti-rMal d 1 and anti-rApi g 1 Fab fragment
libraries were validated by restriction enzyme digestions
and sequencing ten independent clones from each library
(GATC Biotech).
Selection of the mouse IgG antibody libraries
Biotinylated allergens were used in the selection of
mouse antibody libraries. For biotinylation reaction, re-
combinant allergens (Biomay) and bovine serum albumin
(BSA, Sigma Aldrich) used as a negative background con-
trol were diluted in 50 mM sodium bicarbonate buffer,
pH 8.5 or PBS. Protein solutions were incubated with
10 mM biotin reagent (EZ-Link Sulfo-NHS-LC-Biotin,
Thermo Scientific) for 30 min at room temperature. In
the labeling reaction, a 10-fold molar excess of biotin re-
agent was used. The biotinylation of rMal d 1, rApi g 1,
rBet v 1 and BSA (rMal d 1-Bio, rApi g 1-Bio, rBet v 1-Bio
and BSA-Bio, respectively) was confirmed by immunoblot
using alkaline phosphatase conjugated streptavidin
(Amersham Biosciences) as a detection antibody.
The selection of rMal d 1 and rApi g 1-specific anti-
bodies from the constructed Fab fragment libraries was
based on the specific protein-protein interactions. For
the selection, phage particles displaying Fab fragments
on the surfaces of the filamentous M13 bacteriophages
were prepared. The resulting phagemid DNA from the
Fab fragment library construction was transformed into
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Technologies). The volume of the cultivation was in-
creased with Super Broth (SB) medium supplemented
with carbenicillin (20 μg/ml) and tetracycline (10 μg/ml)
and incubated for an hour at 37°C with agitation
followed by a second supplementation with carbenicillin
(50 μg/ml). The phage particles were then assembled
using a helper phage (Stratagene, VCS M13, 1011 cfu/ml).
After incubation for 30 min at 37°C, the volume of the
cultivation was again increased to 100 ml with SB medium
supplemented with carbenicillin (50 μg/ml) and tetracyc-
line (10 μg/ml). After two hours of incubation at 37°C
with the agitation, the cultivation was supplemented with
kanamycin (70 μg/ml). After an 18-h incubation step at
34°C with the agitation, the phage particles were purified
twice by a precipitation with PEG-6000 (Sigma Aldrich)
and 2.5 M NaCl.
During the selection, anti-rMal d 1 and anti-rApi g 1
antibody phage pools (1010 cfu/ml) were allowed to react
in solution with the biotinylated rMal d 1 (Cfinal = 630
nM) or rApi g 1 (Cfinal = 690 nM), respectively. To con-
trol the allergen-specific binding, the antibody phage
pools were also allowed to react with biotinylated BSA
(Cfinal = 160 nM). After two hours of incubation at room
temperature with rotation, the reaction solutions were
transferred to the SA-coated microtiter plate wells and
incubated for 30 min at room temperature with agita-
tion. After washing step, the specifically bound phages
were eluted with 0.1 M Glycine-HCl, pH 2.0 and imme-
diately neutralised with 2 M Tris. For the next selection
round, the eluted phage pools were amplified by infecting
E. coli XL1-Blue cells and phage particles re-assembled
with helper phages followed by the phage precipitation as
described earlier. Total of two selection rounds were
performed.
Screening of allergen-specific antibodies by ELISA
The preliminary screening of rMal d 1 and rApi g 1
-specific Fab fragments was carried out by ELISA using
Fab fragment phage pools. rMal d 1-Bio, rApi g 1-Bio
and BSA-Bio (0.5 μg) were immobilised on SA-coated
microtiter plate wells as described earlier. Dilution series
of the original phage library as well as amplified Fab
fragment phage pools after each selection round were
added to the allergen-coated wells and incubated for two
hours at room temperature with agitation. Specifically
bound phage particles were detected using anti-M13-HRP
conjugate (GE Healthcare) and 2,2-azino-bis (3-ethyl-
benzothiazoline-6-sulfonic acid) di-ammonium salt
(ABTS, Roche). The absorbance values were measured
at 405 nm.
Based on the phage pool ELISA results, the secondary
screening of individual rMal d 1 and rApi g 1 -specific
Fab fragment clones was conducted by ELISA. Individualbacterial clones were picked from different selection
rounds and grown in Super Broth (SB) medium supple-
mented with ampicillin (100 μg/ml), tetracycline
(10 μg/ml) and 1% glucose in 96-deep well plates for
18 h at 37°C with agitation. The cultivations were then
diluted 1:50 in SB medium to a final volume of 1 ml
supplemented with ampicillin (100 μg/ml) and tetra-
cycline (10 μg/ml) and grown for three hours at 37°C
with agitation. After adding helper phage (109 cfu), the
cultures were subjected to a helper phage infection for
30 min at 37°C and a 2-h period of growth at 37°C with
agitation. Finally, the cultures were supplemented with
kanamycin (70 μg/ml) and cultivated for 18 h at 34°C
with agitation. The cells were then harvested by centri-
fugation (3200 g, 20 min, 4°C). The supernatants con-
taining Fab fragment-pIII fusions were subjected to the
ELISA. The immobilisation of the biotinylated aller-
gens and BSA onto SA-coated wells was carried out as
previously. Phage particles displaying Fab fragments
obtained from the selection rounds were allowed to
bind to the allergen for two hours at room temperature
with agitation. As previously, the specifically bound
phage clones were detected with anti-M13-HRP conju-
gate and ABTS. The absorbance values were measured
at 405 nm. Based on the ELISA results, total of 20
clones, i.e. five clones from each selection round were
subjected to DNA sequencing (GATC Biotech). Se-
quences were aligned with Geneious software (version
6.1.6, Biomatters Ltd) and CDR regions identified.
Production and purification of allergen-specific Fab
fragments
For further characterisation, two mouse anti-rMal d 1
and anti-rApi g 1 IgG Fab fragments were selected
according to the sequence analysis. First, the coding
sequences of the Fd region and light chain of the Fab
fragments were cloned into pKKtac bacterial expres-
sion vector containing the sequence encoding the
hexahistidine tag at the Fd region C-terminus. The
resulting recombinant Fab fragments were produced in
E. coli RV308 strain as described earlier [46]. From the
supernatants, the Fab fragments were purified using
standard immobilised metal ion affinity chromatog-
raphy (IMAC) procedure as described earlier [49].
Briefly, TB (Terrific Broth) medium containing ampicillin
(100 μg/ml) and 0.1% glucose was inoculated 1:50 with
18-h pre-culture of Fab fragments, and grown until OD600
value of 4 was reached. The Fab fragment expression was
induced by adding 1 mM IPTG. The culture medium was
supplemented with additional ampicillin (100 μg/ml)
and cultivated at 30°C and 170 rpm for 18 h. Finally, the
cells were harvested by centrifugation (4500 g, 15 min,
4°C) and the Fab fragments were purified from the
supernatant.
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purified Fab fragments
The allergen-binding specificity of the purified anti-rMal
d 1 and anti-rApi g 1 Fab fragments was analysed by
competitive ELISA. The immobilisation of the biotinyl-
ated allergens onto SA-coated microtiter plate wells was
carried out as described earlier. Purified Fab fragments
at a final concentration of 15 nM were first incubated
with competitor allergen at different concentrations (0.4
nM–14 μM) in solution for an hour at room temperature
with rotation. The allergen-Fab fragment complexes were
then transferred to the allergen-coated SA-wells. Finally,
the amount of bound Fab fragments was detected
using alkaline phosphatase conjugated goat anti-mouse
Ig (H + L) and p-nitrophenylphosphate substrate. The
absorbance values were measured at 405 nm.
Due to known similarity in structures and sequences
between Mal d 1, Api g 1 and Bet v 1, the binding of
rMal d 1 and rApi g 1 -specific Fab fragments against
rBet v 1 was also analysed by ELISA. First, a small scale
production in E. coli RV308 and ELISA with supernatant
samples were carried out as earlier. Then, the binding
properties were further analysed by ELISA using purified
Fab fragments. The biotinylated allergens were immobi-
lised onto SA-coated microtiter plate wells using BSA-
Bio as a negative control. Purified anti-rMal d 1 and
anti-rApi g 1 Fab fragments were allowed to bind to
immobilised allergens at different concentrations (0.03
nM–0.3 μM) for an hour at room temperature with agi-
tation. The detection of the Fab fragment binding was
carried out as described previously.
Surface Plasmon Resonance (SPR) experiments of the
purified rMal d 1 and rApi g 1 -specific Fab fragments
were conducted with BIAcore (T200) at 25°C. Briefly,
seven serially diluted concentrations of MA1, MB3, AH7
or AA11 Fab fragments (0–400 nM) were injected at a
flow of 30 μl/min to Sensor Chip CAP coupled with bio-
tin capture reagent (GE Healthcare) and biotinylated
recombinant allergen. The binding of MA1 and MB3
Fab fragments against rMal d 1 and rBet v 1 as well as
AH7 and AA11 Fab fragments against rApi g 1 and rBet
v 1 was analysed. As a reference, Fab fragment binding to
Sensor Chip CAP with capture reagent was studied. The
results were analysed with the Evaluation T200 -software
with a 1:1 Langmuir binding model.
The ability of the purified Fab fragments to recognise
the apple and celery allergen from natural sources, i.e.
apple and celeriac, respectively, were studied with the
immunoprecipitation assay. Apple and celeriac extracts
were prepared from the locally purchased Golden Deli-
cious apples and raw celery root (celeriac) according to
the method of Björkstén et al. [50]. Briefly, small
pieces of apple and celeriac were frozen with liquid
nitrogen and homogenised prior to suspension into10 mM potassium phosphate buffer (pH 7.0) containing
2% suspended polyvinylpolypyrrolidone (PVPP, Sigma
Aldrich), 2 mM of EDTA (Sigma Aldrich) and 10 mM of
sodium diethyldithiocarbamate (DIECA, Sigma Aldrich).
The homogenate was stirred vigorously for four hours at
4°C and centrifuged (40 000 g, 30 min, 18°C). The super-
natant was passed through a polyvinylidene difluoride fil-
ter with a pore diameter 0.45 μm (Millex) and dialysed
against 10 mM potassium phosphate buffer (pH 7.0) for
18 h at 4°C. The allergen extractions were confirmed by
immunoblot. In the immunoprecipitation assay, both al-
lergen extract and recombinant allergens (Biomay) were
used. The allergen-specific Fab fragments were immobi-
lised onto protein G beads (Dynabeads, Dynal) according
to the manufacturer’s instructions (25 μg protein/ 25 μl
beads). Allergen samples were incubated with protein G-
Fab fragment beads for two hours at room temperature
with rotation. Allergen-Fab fragment complexes were
eluted with 0.1 M glycine-HCl (pH 2.0) and immediately
neutralised with 1 M Tris buffer. The eluted samples were
analysed on silver-stained SDS-PAGE.
The usability of allergen-specific Fab fragments for the
detection of allergens in sandwich ELISA was studied. In
the sandwich ELISA, the immobilised antibody was the
purified Fab fragment (MB3 Fab fragment in the case of
Mal d 1 and AH7 Fab fragment in the case of Api g 1)
whereas the detection antibody was displayed on the tip
of the phage particle (MA1 Fab fragment displaying
phage in the case of Mal d 1 and AA11 Fab fragment
displaying phage in the case of Api g 1). The M13 bacte-
riophages displaying Fab fragments were prepared as
previously. The purified Fab fragments (1 μg) were
immobilised passively on Maxisorp plate wells (Nunc).
After immobilisation, the wells were blocked with PBS
containing 0.5% BSA for an hour at room temperature
with agitation. Then, the allergen (Biomay, 1 μg) was
added followed by the addition of the phage particles
displaying the other Fab fragment specific to the aller-
gen at a concentration of 1010 cfu/ml in PBS contain-
ing 0.05% Tween. The bound phage particles were
detected using anti-M13-HRP conjugate and ABTS as
previously and the absorbance values were measured at
405 nm. As controls, the absorbance of Fab fragment,
phage particles (1010 cfu/ml) displaying the Fab fragment
and helper phage particles (1011 cfu/ml) were analysed.
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